PRIMARY DOCUMENT

Company

Monopar Therapeutics

Filed

August 15, 2019

Accession Number

0001654954-19-009689

An S-1 is a registration statement filed by a company preparing for its initial public offering (IPO). It discloses the business model, financials, risk factors, and use of proceeds. Learn more about S-1 filings →